GLENMARK LIFE SCIENCE LIMITED
Company Profile:
GLENMARK LIFE SCIENCE LIMITED Company Introduction
GLENMARK LIFE SCIENCE LIMITED is a factory.
Company Introduction:
Glenmark Life Science Limited is a leading developer and manufacturer of Active Pharmaceutical Ingredients (APIs). The company focuses on the development, manufacturing, and marketing of high-quality APIs, including those for chronic therapeutic areas such as cardiovascular disease, central nervous system disorders, pain management, and anti-infectives. It is a subsidiary of Glenmark Pharmaceuticals Limited, with a strong emphasis on research and development to create a diverse portfolio of complex and niche APIs. Glenmark Life Science operates multiple manufacturing facilities that are approved by major regulatory bodies worldwide, supplying pharmaceutical companies globally.
Enterprise Products
Glenmark Life Sciences Limited primarily focuses on the development and manufacturing of Active Pharmaceutical Ingredients APIs for various therapeutic areas. Their product portfolio includes a wide range of APIs, some of which are:
Anticancer APIs
Antidiabetic APIs
Antidepressant APIs
Antihistamine APIs
Antihypertensive APIs
Cardiovascular APIs
Central Nervous System CNS APIs
Gastrointestinal APIs
Anti-infective APIs
Anti-inflammatory APIs
Respiratory APIs
Dermatological APIs
Ophthalmological APIs
Specific examples of their APIs include:
Telmisartan
Rosuvastatin
Olmesartan
Perindopril
Rivaroxaban
Saxagliptin
Sitagliptin
Vildagliptin
Linezolid
Favipiravir
Montelukast
Finasteride
Dutasteride
Ezetimibe
Itraconazole
Voriconazole
Ciprofloxacin
Levofloxacin
Moxifloxacin
Amlodipine
Valsartan
Irbesartan
Losartan
Ramipril
Atorvastatin
Simvastatin
Pravastatin
Fluoxetine
Sertraline
Escitalopram
Paroxetine
Citalopram
Fexofenadine
Levocetirizine
Desloratadine
Betahistine
Pantoprazole
Rabeprazole
Esomeprazole
Omeprazole
Lansoprazole
Dabigatran Etexilate
Apixaban
Ticagrelor
Clopidogrel
Prasugrel
Tadalafil
Sildenafil
Vardenafil
Letrozole
Anastrozole
Exemestane
Tamoxifen
Bicalutamide
Flutamide
Nilutamide
Abiraterone Acetate
Enzalutamide
Pomalidomide
Lenalidomide
Daclatasvir
Sofosbuvir
Velpatasvir
Glecaprevir
Pibrentasvir
Ledipasvir
Voxilaprevir
Business Registration Information:
Manager:
Dr. Yasir Rawjee (Managing Director & Chief Executive Officer)
Phone:
E-mail:
investorrelations@glenmarklifesciences.com
Official Website:
Address:
Plot No. S-7, H-6 & H-6/1, Phase II, MIDC, Ambernath (W), Dist. Thane, Maharashtra - 421 501, India
This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.